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Folate is an essential dietary vitamin involved in methylation reactions and DNA 
synthesis.  Insufficient dietary folate has been associated with various developmental and 
adult diseases such as neural tube defects and colorectal cancer.  The basis for these 
associations has not been clearly defined. In microarray studies, components of the Wnt 
signaling pathway have been shown to be altered under folate-deficient conditions. The 
Wnt signaling pathway has multiple functions, affecting cell growth, differentiation, and 
development.  The purpose of this study was to determine if folate deficiency leads to 
altered Wnt signaling with a focus on β-catenin activity, protein levels, and cellular 
localization. NIH3T3 cells containing the TOPFlash β-catenin luciferase reporter were 
grown for 4, 8, and 10 days in folate-deficient and sufficient custom DMEM medium 
either with or without activation of the Wnt pathway by addition of Wnt3a conditioned 
medium. β-catenin activity, as measured by luciferase activity per unit DNA, was higher 
in folate-deficient cells at 8 and 10 days in Wnt3a stimulated cells.  β-catenin protein 
levels as assayed by Western blot analysis were not significantly different in folate-
deficient cells. Indirect immunofluorescence revealed increased nuclear localization of β-
catenin in folate-deficient cells of both Wnt3a stimulated and unstimulated cells at 10 
days.  Overall, these results suggest that folate deficiency alters cell function, in part, due 
to changes in Wnt signaling.   
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CHAPTER I 
INTRODUCTION 
 
Statement of Problem 
The purpose of this study is to determine if folate deficiency leads to alterations in the 
Wnt signaling pathway. 
Folate Uptake and Metabolism 
Folate is a necessary vitamin that must be obtained from the diet. It is found in 
leafy green vegetables, citrus fruits, and organ meats. Folate can also be obtained through 
dietary supplementation in the form of folic acid. Once ingested, folate is taken up by 
enterocytes of the small intestine and enters the blood. Plasma folate is bound to various 
proteins for transport and its level is regulated by the liver. As folate passes through the 
blood it binds to the specific cell surface transporters Folate Binding Protein (FBP) and 
Folate co-Transporter (FcoT) and is transported into the cell.  
Intracellular folate is converted into 7,8 dihydrofolate, which is then converted 
into tetrahydrofolate via dihydrofolate reductase (Fig. 1a). Tetrahydrofolate is converted 
into 5,10-methylenetetrahydrofolate, which can then be converted into 5-methyl-
tetrahydrofolate via 5,10-methylenetetrahydrofolate reductase. The metabolite, 5,10-
methylene tetrahydrofolate, is used to convert deoxyuridylate monophosphate into 
thymidylate monophosphate, a required nucleotide used in DNA synthesis (Fig. 1b). 5-
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methyl-tetrahydrofolate is required for the conversion of homocysteine into 
methionine, which in turn is converted into S-adenosylmethionine,  the major methyl 
donor in methylation reactions of DNA, proteins, and lipids (Ulrich, 2005).   
 
 
Fig. 1. a) Methylation of Homocysteine to Methionine. Dihydrofolate reductase (DHFR), 
methylenetetrahydrofolate reductase (MTHFR), Tetrahydrofolate (THF), S-
adenosylmethionine (SAM), S-adenosylhomocysteine (SAH) (Modified from Ulrich, 
2005) 
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Fig. 1. b) Purine and Pyrimidine Biosynthesis. Dihydrofolate reductase (DHFR), 
methylenetetrahydrofolate reductase (MTHFR), Tetrahydrofolate (THF), Deoxyuridylate 
monophosphate (dUMP), thymidylate monophosphate (dTMP), Thymidylate synthase 
(TS) (Modified from Ulrich, 2005) 
 
 
 
In the absence of folate, deoxyuridylate (dUMP) levels rise and results in dUMP 
being used in place of thymidylate (dTMP) during DNA synthesis (Mashiyama et al, 
2008). This can ultimately result in DNA damage through mutations and or chromosome 
breakage (Blount et al, 1997). In addition to accumulation of dUMP, folate deficiency 
can lead to a failure to convert homocysteine to S-adenosylmethionine. The inability to 
methylate DNA has a variety of cellular consequences, including the alteration of gene 
expression, chromosome damage, and increased rates of gene mutation (Zingg and Jones, 
1997). Moreover, changes in protein methylation, in particular methylation of Ras, has 
been detected, which has been associated with altered function (Winter-Vann et al, 2003).  
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Folate and Cancer 
Epidemiological studies have suggested that a diet low in unsaturated fat, rich in 
fruits and vegetables, and containing adequate amounts of calcium, fiber, and vitamins, 
including folate can reduce cancer risk (Gridley et al, 1992; Willett et al, 1990; Lee et al, 
2006). There have been numerous studies reporting a link between folate status and 
certain types of cancer including colorectal, breast, cervical, esophageal, gastric, hepatic, 
lung, pancreatic, neuroblastoma, and leukemias (Lin et al, 2006). In one study, 
researchers observed a 40% reduction in colorectal cancer risk in individuals that 
obtained a high amount of folate (Kim, 2004).  
Strong evidence for a link between folate deficiency and colorectal cancer was 
provided in the study by Chen (Chen et al, 1996) in which certain polymorphisms in the 
gene coding for 5,10-methylenetetrahydrofolate reductase were detected with a high 
frequency in individuals with colorectal cancer. In another study, knockout mice were 
created that were heterozygous for the folate transporters Folbp1 and Rfc1 (Ma et al, 
2005). This effectively reduced the number of folate transporters in these mice, allowing 
researchers to investigate the effects of folate deficiency on colon cancer. As a result of 
this downregulation, the expression of particular genes associated with colon cancer, 
including Cdh1, Dcn, Esr1, Igf2, and Pik3cg, were altered. An increase in cell 
proliferation within colonocytes was also detected in the knockout mice when compared 
to wild type. Upon inspection of colon tissue in the knockout mice, an increase in lesions 
as well as tumors were detected.  
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WNT Ligands and Signaling 
There are currently 19 known Wnt genes, coding for a like number of signaling 
proteins. Wnt proteins are secretory and have been shown to be localized many cells 
away from their sites of origin (Nusse, 2005). These proteins have a variety of roles and 
functions in cell growth, movement, orientation, and differentiation. Generally, these 
various functions can each be regulated by any one particular Wnt protein. The Wnt 
proteins are highly conserved, indicating an essential role in normal cellular growth and 
maintenance in eukaryotes (Miller et al, 1999).  
There are two primary Wnt pathways: the canonical pathway and the non-
canonical or calcium pathway. In the canonical pathway (Fig. 2), a Wnt ligand binds to 
the cell surface receptors frizzled (FRZ) and low density lipoprotein receptor-related 
protein (LRP). This in turn promotes the formation of the Wnt receptor complex by Axin 
associating with Disheveled (DSH) and the LRP receptor. In unstimulated cells, Axin, 
Glycogen Synthase Kinase 3 (GSK-3), and Adenomatosis Polyposis Coli (APC) form a 
complex that leads to the phosphorylation of β-catenin by GSK-3. β-catenin is then 
ubiquitinated and degraded by proteolytic activity. The formation of the Wnt receptor 
complex inhibits the activity of the axin, GSK-3, APC complex. Consequently, 
cytoplasmic β-catenin levels rise due to reduced degradation. The β-catenin moves into 
the nucleus where it interacts with T-cell factor (TCF) and binds to specific gene 
promoters activating transcription of target genes, such as c-myc, cyclin D, and c-jun 
(Polakis, 2000).  
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Fig. 2. The Canonical Wnt Signaling Pathway. (Modified from 
www.stanford.edu/~rnusse/pathways/celldouble.html) 
 
 
There are many ways in which the non-canonical Wnt pathway can be activated. 
Each begins with the binding of a Wnt ligand to a cell surface receptor and through a 
series of events intracellular calcium concentrations rise, Phospholipase C, Protein 
Kinase C, and the transcription factor NF-AT are activated (Veeman et al, 2003). It has 
been suggested that some intermediates of the non-canonical pathway are able to inhibit 
the canonical pathway (Topol et al, 2003).  
WNT Signaling and Cancer 
Abnormal expression of Wnt proteins has been found to be associated with 
developmental defects and changes in cell growth and function. Various studies have 
  7 
 
shown that an increase or decrease in the expression of certain Wnt genes in various 
forms of cancer (Moon et al, 2002). In colorectal cancer, APC mutations are nearly 
always detected in tumor tissue (Luebeck and Moolgavkar, 2002). APC would normally 
be involved in the ubiquitination and subsequent degradation of β-catenin, thus reducing 
gene expression. Reduced levels of APC result in increased amounts of β-catenin, 
ultimately leading to increased expression of Wnt target genes (Shiratsuchi et al, 2007).  
Lugli et al. (2007) performed microarray studies of colorectal tumors and 
observed decreased APC expression, which resulted in increased nuclear β-catenin levels. 
Tumors with lower amounts of cytoplasmic APC and higher amounts of nuclear β-
catenin were associated with increased invasiveness, poorer prognosis, and increased 
transcription of β-catenin target genes. 
To further support the hypothesis that increased nuclear β-catenin results in 
altered transcription in colorectal cancer, Dillard and Lane (2007) treated a colon cancer 
cell line with retinol and observed a significant decrease in nuclear β-catenin localization. 
Researchers then measured the amount of β-catenin induced transcription as well as 
mRNA levels of genes involved in cell proliferation and found a significant decline in 
gene expression.   
Linking Folate Deficiency, the Wnt Pathway, and Cancer 
As discussed, reduced folate levels have profound cellular effects that may 
include increased DNA damage and mutation rates, in addition to altered methylation 
patterns due to reduced S-adenosylmethionine. As a secondary effect, changes in gene 
expression have been detected in folate-deficient cells (Crott et al, 2007; Katula et al, 
  8 
 
2007; Zhenhua et al, 2007). It is likely that one or more of these alterations are 
responsible for the link between folate deficiency and cancer, in particular colorectal 
cancer, although the causative mechanism is not known. One possibility not thoroughly 
explored is that changes in specific cell signaling pathways that occur as a response to 
cells adapting to low folate conditions results in cancer. 
A microarray study comparing folate-deficient to folate-sufficient cells revealed 
that expression of particular Wnt signaling pathway genes were altered (Katula et al, 
2007; Crott et al, 2007). Up-regulated genes included both Wnt5a and Wisp1. Dkk1, a 
Wnt pathway inhibitor, was shown to be down-regulated (Katula et al, 2007). In a more 
recent study, upregulation of both APC and β-catenin mRNAs were detected as folate 
levels were decreased in normal human colon cell lines, again showing an association 
between folate status and the Wnt pathway in cell culture (Crott et al, 2007). In an 
additional study, depletion of folate and other B vitamins resulted in an increase in 
neoplastic transformation in the colon cells of mice, this also resulted in global DNA 
hypomethylation, and alterations to the Wnt pathway, including APC and β-catenin 
(Zhenhua et al, 2007).   
Additional indirect evidence that the folate pathway may be linked to the Wnt 
pathway is derived from investigation of gene expression in mice that exhibited 
hyperhomocysteinemia (Ernest et al, 2002). As previously mentioned, 5-methyl-
tetrahydrofolate is used to convert homocysteine into methionine. Mice with elevated 
homocysteine levels produce a phenotype which is very similar to that of mice with 
certain Wnt pathway abnormalities. Gene expression profiles confirmed that mice with 
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mutations in the Wnt pathway have higher homocysteine levels. In another study, a 
mouse genetic model for a folate-responsive neural tube defect, crooked tail (cd) was 
found to have a mutation in a Wnt coreceptor, LRP6, which eliminates its regulation by 
the Dkk1 Wnt ligand (Carter et al, 2005). These findings provide further support for a 
link between the folate metabolic pathway and Wnt signaling. 
It is the major aim of this study to determine the effect of folate deficiency on the 
Wnt signaling pathway. 
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CHAPTER II 
MATERIALS AND METHODS 
 
Preparation of Custom Medium  
Delbecco’s Modified Eagle’s Medium (DMEM) was prepared using the 
formulation of the American Type Culture Collection (ATCC) (Appendix A) with the 
exception that folate was initially excluded. After mixing, the medium was equally 
separated into two batches. Folate was added to one batch (2 mg/L) but not the other. The 
medium was filter sterilized (0.20 µm filter). Complete medium was made by adding 50 
ml of filter sterilized dialyzed calf serum (dcs) to 450 ml of DMEM from each batch, 
along with 5 ml of 100X Penicillin/Streptomycin (10,000 IU/ml 10,000 µg/ml). This 
medium is referred to as DMEM Complete With (folate) and DMEM Complete No 
(folate).    
Cell Lines 
 NIH 3T3 cells transfected with the TOP/FOP Flash reporter vectors (obtained 
from Randall Moon, University of Washington, Howard Hughes Medical Institute, 
Department of Pharmacology) were used as a cell model. The cell lines are referred to as 
TOPFlash-3T3 and FOPFlash-3T3. The TOP/FOP Flash reporter system allows for the 
determination of β-catenin activity. The TOPFlash construct has three β-catenin binding 
sites in the promoter of the coding region of a luciferase gene. Increased binding of β-
catenin results in the increased expression of luciferase. The FOPFlash reporter construct 
serves as a control for the TOPFlash plasmid. The β-catenin binding sites in the 
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FOPFlash plasmid have been mutated so that β-catenin will not bind, and essentially no 
luciferase should be transcribed. 
Cell Culture 
TOPFlash 3T3 and FOPFlash 3T3 cells were grown in DMEM Complete medium 
until 80% confluence. On day 0, the cells were collected by trypsinizing and replated. 
Cells were plated at a starting density of 5.6 X 105 cells per T-75 flask and brought up to 
12 ml with either DMEM Complete, with or no. 10 µl of G418 was then added to each T-
75 flask. Cells were grown at 37° C in a 5% carbon dioxide atmosphere.  
On day 2 of the culture period, the cells that were utilized for the second time 
point (day 8) were collected and re-plated at 5.6 X 105 cells per flask. On the same day, 
cells to be used for the first time point (day 4) were collected and re-plated for treatment 
with conditioned medium. The following day (day 3), the cells for the first time point 
were treated with either L-cell or Wnt3a conditioned medium (see preparation of 
conditioned medium), which was diluted 1:1 with fresh medium (DMEM Complete No). 
The medium was removed from cells and replaced with conditioned medium. Cells for 
the first time point were then collected on day 4. Also on day 4, cells used for the second 
time point (day 10) were collected and re-plated at 5.6 X 105 cells per flask. At day 6, the 
cells used for the day 8 time point were again collected and re-plated for treatment with 
conditioned medium. The following day (day 7), the cells were treated with either L-cell 
or Wnt3a conditioned medium, which was diluted 1:1 with fresh medium (DMEM 
Complete No). The medium was removed from cells and replaced with conditioned 
medium. Cells were collected at day 8. Cells for the second time point (day 10) were re-
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plated for treatment on day 8. The following day (day 9), the cells were treated with 
conditioned medium. Cells were then collected on day 10. Collected cells were assayed 
for luciferase, Western  blot, or immunofluorescent analysis.  
Preparation of Conditioned Medium 
Two cell lines were obtained from the American Type Culture Collection 
(ATCC), L-cell with a Wnt3a expression vector (CRL-2647) and a normal L cell line 
(CRL-2648). Cells were initially grown to near confluency in T-75 flasks. The cells were 
collected, brought to 10 ml in DMEM Complete, and replated at a 1:10 dilution in ten 
100 mm plates. On day 4, the medium was removed, filtered, and stored at 4° C. An 
additional 10 ml of DMEM Complete was added to each 100 mm dish and the cells were 
allowed to grow for an additional 3 days. At day 7, the medium was removed, filtered, 
and combined with the medium collected on day 4. The medium was then stored at -20° 
C. 
In Situ Immunofluoresence 
TOPFlash 3T3 cells were grown for 4, 8, and 10 days in folate-deficient and 
sufficient medium. Two days prior to collection, the cells were grown directly on 
coverslips in 24 well dishes. The day prior to collection, the cells were treated with 
Wnt3a or L-cell conditioned medium as previously described. Cells were fixed directly in 
24-well plates with 1 ml 2% formaldehyde in phosphate buffered saline (PBS) for 15 
minutes. Following fixing, cells were washed three times with 500 µl PBS for five 
minutes per wash. Cells were stored in 500 µl PBS at 4°C. 
Cells were permeabilized with 1 ml 0.25% Triton X-100 diluted in PBS for 5 
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minutes. Following permeabilization, cells were washed three times with 500 µl PBS. 50 
µl of a 20 µg/ml dilution of a mouse anti-β-catenin antibody (Zymed Laboratories, 
catalogue# 138400) was added directly onto the cells and incubated at 37° C  for 90 
minutes. Following incubation, cells were washed three times with PBS for 5 minutes per 
wash. 50 µl of a secondary antibody, goat anti-mouse IgG, with fluoroform Alexa 488 
(Invitrogen, catalogue# A11001), diluted 5 µg/ml was then applied. Cells were then 
shielded from light and incubated at room temperature for one hour. Cells were then 
washed three times with 500 µl PBS for five minutes per wash. Nuclei counterstaining 
was performed with 300 µl of a 1:100,000 dilution of DAPI for 5 minutes at room 
temperature. Cells were then washed twice with 500 µl PBS for 5 minutes. Coverslips 
were mounted on glass slides using Dako Cytomation Fluorescent Mounting Medium 
(catalogue# S3023). Cells were then imaged using confocal microscopy (Olympus 
FV500) and the Fluoview imaging software (Olympus). A single plane of .5 µm was used 
for imaging. Quantification of imunofluorescent signal was obtained using the ImageJ 
software. Average nuclear signal was measured along with average cell signal.  
Luciferase Assay 
Cells used for luciferase assay analysis were collected by trypsinization, 
resuspended in PBS, and counted. Equal cell numbers were aliquoted into glass tubes and 
the cells pelleted by centrifugation at 2,000 rpm. The supernatant was removed and the 
cells resuspended in 1X Cell Lysis Buffer (Promega, Inc) for 15 minutes at 37° C . 
Lysates were transferred to microcentrifuge tubes and stored at -20° C.  Luciferase was 
measured using the Luciferase Assay System (Promega, Inc.). 20 µl of cell lysate was 
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pipeted into luminometer tubes. Readings were then taken using a Berthold LB 9501 
luminometer. Variability in cell number between samples was accounted for by 
measuring DNA and standardizing luciferase results to quantified DNA (see DNA 
quantification).  
Western Blot 
TOPFlash 3T3 cells were grown for 4, 8, and 10 days in folate-deficient and 
sufficient medium. Two days prior to collection cells were grown in 100 mm dishes. The 
day prior to collection, each group of cells was stimulated with either a Wnt3A 
conditioned medium, or an L-cell control. 
Cells used for Western blot analysis were collected by trypsinization, resuspended 
in PBS, and counted. Equal cell number was aliquoted into glass tubes tubes and the cells 
pelleted by centrifugation. The supernatant was removed and the cells resuspended in 
Cell LyticTM  M Cell Lysis Reagent (Sigma, catalogue# C2978). Samples were incubated 
at room temperature for 15 minutes and transferred to microcentrifuge tubes. Lysates 
were centrifuged at 14K for 5 minutes, the supernatant transferred to a clean 
microcentrifuge tube and stored at -80°C. Protein content of the samples was then 
determined (see protein quantification).  
An equal amount (equal cell number or equal amount of cellular protein) of each 
sample group was loaded into separate wells of an acrylamide gel (10%). Prestained 
molecular weight markers (Colorburst; Sigma, catalogue# C4105) was loaded into one 
lane of the gel. Electrophoresis was performed for 3 hours at 21 mA. 
Following electrophoresis, protein was transferred to nitrocellulose using standard 
  15 
 
methods.  
The next day, the blot was initially stained in Ponceau S (1% in 1% acetic acid 
diluted 1:10 with ddH20) to visualize the proteins and confirm equal loading. The blot 
was incubated in 5% milk in Tween-Tris Buffered Saline (TTBS) (.15M NaCl, .01M Tris 
pH 8.0, 500 µl Tween) for one hour. A 1:500 dilution of mouse anti-β-catenin (Zymed 
Laboratories, catalogue# 138400) and 1:200 dilution of mouse anti-tubulin antibodies 
(Developmental Studies Hybridoma Bank) in 1% milk in TTBS was added to the blot for 
one hour. A 1:500 dilution of mouse anti-LRP6 (Santa Cruz Biotechbnology Inc, 
catalogue# sc-25317) and a 1:200 dilution of mouse anti-tubulin antibodies in 1% milk in 
TTBS was added to the blot for one hour to determine LRP6 content. The nitrocellulose 
filter was then washed in TTBS three times for five minutes and once for 15 minutes. A 
1:10,000 dilution of goat anti-mouse horse radish peroxidase (Sigma, catalogue# A3673) 
in 1% milk in TTBS was placed on the nitrocellulose for one hour. The nitrocellulose was 
again washed three times in TTBS for 5 minutes and once for 15 minutes. The 
Supersignal West Femto Chemiluminescent detection kit (Pierce, catalogue# 34095) was 
used to detect the antibody on the nitrocellulose. Imaging was performed on a Biorad 
Chemi Doc XRS imager using the Quantity One software. Variation in loading was 
accounted for by quantifying tubulin and standardizing β-catenin and LRP6 accordingly. 
Protein Quantification 
Protein content of the Western blot samples were determined as follows: 
Generally, 10 µl of cell lysates were added to 790 µl of ddH2O and 200 µl of Bradford 
dye (Bio Rad, catalogue# 500-0006) was added. A bovine serum albumin (BSA) standard 
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of 0, 2, 5, 10, 15, and 20 µg of protein was also prepared. Light absorbance was measured 
at 595 nm using a Genesis 10UV spectrophotometer. Unknown protein contents were 
determined using the generated BSA standard curve. 
Quantification of DNA 
 10 µl of each cell lysate sample was placed in a 96 well plate. 50 µl of a DNA 
binding dye (Invitrogen; CyQuant NF Cell Proliferation Assay Kit, catalogue# C35006) 
diluted 1:750 in 1X Hank’s Buffered Salt Solution (HBSS) was then added to each well. 
The samples were shielded from light and incubated at 37°C for 15 minutes. Samples 
were measured on a BIO-TEK Synergy HT microplate reader, excitation set at 485 nm 
and emission detection at 530 nm using the KC4 software. 
Statistics 
 For the luciferase assay there were 2 biological replicas performed, included in 
this were 6 technical replicas (for unstimulated cells at day 10 at least 3 technical replicas 
were performed).  P-values were determined using a two-tailed student T-test with 
significance given to values <0.05. 
 For the Western blot, three biological replicas were used to determine β−catenin 
protein content. P-values were determined using a two-tailed student T-test with 
significance given to values <0.05. Two biological replicas were used to determine LRP6 
protein content and averages were reported.  
 For immunofluorescent quantification of β−catenin localization, a minimum of 34 
cells were analyzed over 2 biological replicas. P-values were determined using a two-
tailed student T-test with significance given to values <0.05.    
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CHAPTER III 
 
RESULTS 
 
 
 
β−catenin Activity in Folate-Deficient and Sufficient Cells   
Based on the finding that Wnt signaling components are altered due to folate 
deficiency (Katula et al, 2007; Crott et al, 2007; Liu et al, 2007) we decided to determine 
the effect of folate deficiency on β−catenin activity. It was expected that β−catenin 
activity would increase. 
In order to explore this possibility, NIH 3T3 cells that had been stably transfected 
with the TOP/FOP Flash reporter system (Katula lab) were used as an experimental 
system. The TOPFlash plasmid contains a luciferase gene controlled by a promoter with 
three β−catenin binding sites. Thus, a higher level of luciferase activity indicated more 
activated β−catenin. The FOPFlash plasmid contains mutated β−catenin binding sites 
such that β−catenin will not bind and no luciferase will be transcribed, and served as a 
control. 
The TOPFlash-3T3 and FOPFlash-3T3 cells were grown for 4, 8, and 10 days in 
folate-deficient and sufficient medium using a protocol that maintains subconfluent cell 
densities (see Materials and Methods). At each time point cells were collected and 
assayed for luciferase activity. As folate-deficient cells proliferate at a slower rate, 
particularly after seven days, we controlled for cell number in two ways. First, folate-
sufficient and deficient cells were collected, counted, and equal cell number aliquoted. 
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Second, the DNA content of the cell lysates was determined.   
At day 4 of the culture period there was no significant change in β−catenin 
activity (reported as relative light units per unit DNA) in cells grown under folate-
deficient conditions, compared to those grown under folate-sufficient conditions for both 
Wnt stimulated (p<0.069) (Fig. 3) and unstimulated samples (p<0.481) (Fig. 4). This lack 
of differential activity between the folate-deficient and sufficient groups could be due to 
the fact that with just four days of growth in folate-deficient medium, cellular levels of 
folate or folate pathway intermediates were not yet exhausted.  
At day 8 of the culture period there was a significant change in β−catenin activity 
when comparing cells grown under folate-deficient and sufficient conditions. There was 
nearly a 3 fold increase in β−catenin activity in Wnt stimulated folate-deficient cells 
compared to Wnt stimulated folate-sufficient cells (p<0.0003) (Fig. 3). When comparing 
unstimulated cultures there was no significant difference in β−catenin activity (p<0.074) 
(Fig. 4). 
At day 10 of the culture period there was a significant change in β−catenin 
activity in both Wnt stimulated cultures (p<0.0003) (Fig. 3). An unexpected result was 
obtained in unstimulated cultures, where folate-sufficient cells showed greater β−catenin 
activity than did folate-deficient cells (p<0.0281) (Fig. 4). This could be explained by the 
low level of luciferase activity due to the cells not being stimulated. These results do 
show that folate status has an effect on β−catenin activity. 
The FOPFlash cells showed little luciferase activity in both stimulated and 
unstimulated cultures, as expected (data not shown). This result confirms that luciferase 
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activity observed in the TOPFlash cells was due to increased β−catenin activity in the 
promoter of the luciferase gene in the TOPFlash plasmid.  
 
 
     Fig. 3. Alterations in β−catenin Activity in Stimulated Folate-Deficient Cells. 
β−catenin activity reported as RLU per unit DNA in TOPFlash-3T3 cells stimulated with 
Wnt3a conditioned medium and grown under folate-deficient (blue) and sufficient (red) 
conditions for 4, 8, and 10 days. Error bars represent standard error with P values 
reported (n=12).  
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     Fig. 4. Alterations in β−catenin Activity in Unstimulated Folate-Deficient Cells. 
β−catenin activity reported as RLU per unit DNA in TOPFlash-3T3 cells without 
stimulation and grown under folate-deficient (blue) and sufficient (red) conditions for 4, 
8, and 10 days. Error bars represent standard error with P values reported (n=12).  
 
 
β−catenin and LRP6 Protein Levels 
 
 One possible explanation for the increase in β−catenin activity in folate-deficient 
cells is an increase in Wnt pathway receptors; this would allow for more binding of Wnt 
ligands and result in less β−catenin degradation by proteosomes. Another explanation is 
an increase in the amount of β−catenin present in folate-deficient cells.  
 In order to explore these two possibilities, cells were grown under folate-
sufficient and deficient conditions for 4, 8, and 10 days. Cells were lysed and a Western 
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blot performed to determine overall β−catenin and LRP6 protein levels.   
Western blot analysis (Fig. 5) of folate-deficient compared to folate-sufficient 
cells revealed a slight increase in β−catenin protein levels at day 10 when standardized to 
tubulin, however this increase was not significant. There was no significant or observable 
difference in β−catenin protein at the day 4 or 8 time periods (Fig. 6). 
  
 
Fig. 5. Western Blot of β−catenin, LRP6, and Tubulin. Detection of β-catenin and LRP6 
protein in Wnt3a stimulated and unstimulated folate-deficient and sufficient NIH3T3 
cells. Cells were grown for 4, 8, and 10 days in folate-deficient or sufficient medium as 
descibed (Materials and Methods) and treated with Wnt3a or L-cell conditioned medium. 
Cell lysates were prepared and 10µg electrophoresed. TNL; TOPFlash, No folate, L-cell 
conditioned medium. TWL; TOPFlash, With folate, L-cell conditioned medium. TNW; 
TOPFlash, No folate, Wnt3a conditioned medium. TWW; TOPFlash, With folate, Wnt3a 
conditioned medium. The numbers indicate the day of cell collection. 
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Fig. 6. β−catenin Fold Increase in Folate-Deficient/Folate-Sufficient Cells. Fold increase 
in β−catenin in folate-deficient cells compared with folate-sufficient cells grown for 4, 8, 
and 10 days with Wnt3a stimulation (Wnt) or no stimulation (L). Error bars represent 
standard error with P values reported (n=3). 
 
 
 
Western blot analysis (Fig. 7) of folate-deficient compared to folate-sufficient cells 
revealed no signficant difference in LRP6 levels at the day 4, 8, or 10 time periods.  
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Fig. 7. LRP6 Fold Increase in Folate-Deficient/Folate-Sufficient Cells. Fold increase in 
LRP6 in folate-deficient cells compared with folate-sufficient cells grown for 4, 8, and 10 
days with with Wnt3a stimulation (Wnt) or no stimulation (L). Results are reported as an 
average (n=2). 
 
 
β−catenin Localization 
 
We found that β−catenin activity increases in folate-deficient cells but there was 
no significant change in Wnt pathway receptor LRP6 and β−catenin protein levels. One 
explanation is that a greater fraction of β−catenin is localizing to the nucleus. β−catenin 
cellular localization was examined by immunofluorescence. 
Cells were grown under folate-sufficient and deficient conditions for a period of 
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4, 8, and 10 days. Cells were fixed, immunostained for β−catenin, and analyzed by 
confocal microscopy (Fig. 8). Total cell signal and nuclear signal were quantified and the 
proportion of nuclear/cell signal determined as a measure of β−catenin protein 
distribution.  
Analysis of immunofluorescent images at all three time points (day 4, 8, and 10) 
showed an increase in nuclear localization of β−catenin in Wnt stimulated cells when 
compared to unstimulated cells regardless of folate status. This is as would be expected, 
since activation of the Wnt pathway by Wnt3a ligand binding leads to stabilized 
β−catenin and increased nuclear localization.  
 
 
(Fig. 8 legend next page) 
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Fig. 8. Immunofluoresent Staining for β−catenin Localization. A) immunofluorescent 
staining of cells grown for 4 days under folate-sufficient (with) or deficient (no) 
conditions and either stimulated (Wnt3a) or unstimulated (L-cell).  B) cells grown for 8 
days under with/no and Wnt/L-cell conditions. C) cells grown for 10 days under with/no 
and Wnt/L-cell condition. Cells were immunostained for β−catenin. 
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When quantifying nuclear signal to overall cell signal per unit area for day 4 
samples there was an increase in β−catenin nuclear localization in folate-deficient cells 
compared to folate-sufficient cells (Fig. 9). However, the reported increase in nuclear 
localization is not significant in unstimulated cells (p<0.137). In Wnt stimulated cells, a 
significant difference in nuclear localization was observed (p<0.026). 
Quantitative analysis of day 8 samples show a significant increase in nuclear 
β−catenin localization in folate-deficient Wnt3a stimulated cells versus stimulated folate-
sufficient cells (p<0.000003). Unstimulated treatment groups did not show a significant 
increase in nuclear localization (p<0.069) (Fig. 9). Although not significant, there was 
still an observed increase in nuclear localization of β−catenin in unstimulated folate-
deficient cells compared with unstimulated folate-sufficient cells.     
Quantitation of day 10 samples show a significant increase in nuclear β−catenin 
localization in both stimulated (p<0.00003) and unstimulated cells (p<0.002) when 
comparing folate-deficient cells to folate-sufficient cells (Fig. 9). 
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Fig. 9. Nuclear Localization/Cytoplasmic Localization of β−catenin. NIH3T3 cells grown 
for 4, 8, and 10 days under folate-sufficient and deficient conditions. Nuclear localization 
of β−catenin reported as nuclear signal per unit area/cytoplasmic signal per unit area. 
Error bars represent standard error with P values reported (n>80). 
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CHAPTER IV 
DISCUSSION 
 
It has been reported that folate deficiency leads to an increased risk for various 
cancers (Lin et al, 2006). The strongest association is that between folate status and 
colorectal cancer (Kim, 2004). It has also been observed that certain Wnt pathway 
abnormalities are present in many cancers, including colorectal cancer (Lugli et al, 2007). 
Microarray studies of folate-deficient cells have suggested a strong association between 
folate status and alterations in the Wnt signalling pathway (Crott et al, 2007; Katula et al, 
2007). In vivo studies of folate deficiency have also shown alterations in the Wnt 
signaling pathway (Zhenhua et al, 2007). The mechanism for this association has never 
been fully explored. The data collected in this study shows a distinct association between 
between folate status and alterations in the canonical Wnt signalling pathway through 
changes in β−catenin activity and localization.  
A significant increase in β−catenin transcriptional activity was observed within 
eight days of growth under folate-deficient conditions. This increase in activity shows a 
correlation between folate status and the canonical Wnt signalling pathway. The increase 
in β−catenin activity can be explained in many different ways. The possibilities examined 
in this study were: 1) an increase in the amount of β−catenin protein; 2) an increase in the 
Wnt signalling receptors; 3) an increase in β−catenin nuclear localization.  
 An increase in the β−catenin protein was observed in folate-deficient cells 
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compared to folate-sufficient cells, however, the difference was not significant. Likewise, 
there was no significant change in the amount of LRP6 receptor proteins in folate-
deficient cells compared to folate-sufficient cells. This result shows that the observed 
increase in β−catenin transcriptional activity was not due to an increase in these Wnt 
pathway proteins.  
Since β−catenin is a transcription factor, it must localize to the nucleus to have a 
transcriptional effect. It was observed that there was a significant difference in nuclear 
localization of β−catenin as early as day 4 of growing Wnt stimulated cells under folate-
deficient conditions. Active β−catenin would normally be located in the nucleus 
associating with TCF to promote transcription (Polakis, 2000). In unstimulated cells, 
β−catenin is found in the cytoplasm, associated with the axin, GSK-3, APC complex, 
which leads to it’s ubiquitination and degradation via proteosomes. β−catenin can also be 
found associated with the cell membrane and E-cadherin (Lugli et al, 2007). The 
increased localization of β−catenin to the nucleus and the lack of an increase in the 
β−catenin protein indicates a reduction in cytoplasmic and cell membrane associated 
β−catenin. Although the mechanism directing β−catenin nuclear localization is not 
completely understood, it does appear the folate status may play a role in enhancing or 
directing the effect. It was shown in hepatocarcinomas that the level of E-cadherin 
decreases and increased localization of β−catenin to the nucleus occurs (Wilhelm et al, 
2003). Insulin-like growth factor 1 (IGF-1) has been shown to play a role in the 
localization and activity of β−catenin through causing an association of β−catenin and E-
cadherin at the cell membrane (Playford et al, 2000). It has also been shown that folate 
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status plays a direct role in IGF-1 protein expression (Istiadjid, 2005). It is plausible that 
folate deficiency may cause a decrease in the IGF-1 protein which ultimately could result 
in β−catenin dissociating from E-cadherin and the cell membrane and localizing to the 
nucleus. This hypothesis could be further examined by measuring the level of IGF-1 
expression in folate-deficient cells.  
The other Wnt pathway components that should be studied, includes the FRZ 
receptor. An increase in the amount of FRZ receptor proteins could explain the increase 
in β−catenin activity via increased nuclear localization. In fact, in a study by Bliek et al 
(2004), the FRZ (Frizzled) protein was upregulated during embryogenesis under folate-
deficient conditions.  
Another Wnt pathway component that could effect β−catenin activity and not 
cause an increase in the β−catenin protein would be the cofactor T-cell factor (TCF). An 
increase in the nuclear amount of TCF could result in increased transcription of Wnt 
pathway target genes, independent of β−catenin protein levels. APC levels have been 
suggested to be altered in colorectal cancer (Lugli et al, 2007). APC is involved in the 
complex which degrades β−catenin. An increase in APC would result in β−catenin 
degradation, however a decrease in APC would result in the stabilization of β−catenin. In 
addition, APC, has been shown to bind to the enhancer of the c-myc gene (Sierra et al, 
2006), a gene that is overexpressed in a wide range of cancers and which β−catenin plays 
a role as a transcription factor. The GSK-3β protein could also effect β−catenin activity 
and localization independent of the amount of β−catenin protein present. GSK-3β is 
another protein involved in the complex which results in β−catenin degradation. GSK-3β 
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causes β−catenin to be degraded through phosphorylation which in turn results in 
β−catenin being ubiquitinized and subsequently broken down by proteosomes. A loss of 
GSK-3β activity would result in β−catenin stabilization.  
 Another possiblility in how folate deficiency may effect the Wnt signaling 
pathway is through global hypomethylation. Due to reduced intracellular folate levels, a 
reduction of S-adenosylmethionine (SAM) would result. As previously discussed, SAM 
is the major methyl donor for all methylation reactions. Global hypomethylation has been 
associated with improper gene regulation and cancer. Hypomethylation has also been 
positively associated with the ability of TCF to bind to the promotors of Wnt target genes 
(Wohrle et al, 2007). A lack of methylation would result in more TCF binding, in the 
presence of additional β−catenin, this would result in increased transcription of Wnt 
target genes.  
 In a study by Zhenhua et al (2007) folate depletion in mice did not result in 
significant global hypomethylation, however, when combined with the reduction of other 
1-carbon nutrients such as riboflavin, viatmin B-6, and vitamin B-12, a nearly 50% 
reduction in genomic DNA methylation was observed. It was observed that these 1-
carbon dietary depletions resulted in increased proliferation of colonic cells. In addition, 
there were notable changes in the Wnt signaling pathway. One change in the Wnt 
signaling pathway that was observed was in increase in β-catenin when mutiple 1-carbon 
compounds were depleted. An increase in β-catenin nuclear localization was also 
observed. These in vivo studies confirm the findings of this study, that folate status has an 
effect on the Wnt signaling pathway. 
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 For future studies, levels of other Wnt signaling proteins, including: FRZ, APC, 
GSK-3β, and TCF will be analyzed. In addition, proteins normally seen to associate with 
β−catenin and control its localization could also be analyzed, these include E-cadherin 
and IGF-1.
  33 
 
REFERENCES 
 
Blount BC, Mack MM, Wehr CM, Macgregor JT, Hiatt RA,Wang G, Wickramasinghe 
SN, Everson RB, Ames BN. (1997) Folate deficiency causes uracil misincorporation into 
human DNA and chromosome breakage: Implications for cancer and neuronal damage. P 
Natl Acad Sci USA 94 (7): 3290-3295 
 
BliekJB, de Klein A, Luider TH, Lindemans J, Hulsman L, Guzel C, de Groot C, 
Steegers-Theunissen R. (2004) New approach for the identification of folate-related 
pathways in human embryogenesis. Cell Mol Biol 50 (8): 939-944 
Carter M, Chen X, Slowinska B, Minnerath S, Glickstein S, Shi L, Campagne F, 
Weinstein H, Ross ME. (2005) Crooked tail (Cd) model of human folate-responsive 
neural tube defects is mutated in Wnt coreceptor lipoprotein receptor-related protein 6. P 
Natl Acad Sci USA 102 (36): 12843-12848 
Chen J, Giovannucci E, Kelsey K, Rimm EB, Stampfer MJ, Colditz GA, Spiegelman D, 
Willett WC, Hunter DJ. (1996) A methylenetetrahydrofolate reductase polymorphism 
and the risk of colorectal cancer. Cancer Res 56 (21): 4862-4864 
Crott JW, Zhenhua L, Keyes MK, Choi SW, Jang H, Moyer MP, Mason JB. (2007) 
Moderate folate depletion modulates the expression of selected genes involved in cell 
cycle, intracellular signaling and folate uptake in human colonic epithelial cell lines. J 
Nutr Biochem: 1-8 
Dillard AC, Lane MA. (2007) Retinol decreases beta-catenin protein levels in retinoic 
acid-resistant colon cancer cell lines. Mol Carcinogen 46 (4) : 315-329 
Ernest S, Christensen B, Gilfix BM, Mamer OA, Hosack A, Rodier M, Colmenares C, 
McGrath J, Bale A, Balling R, Sankoff D, Rosenblatt DS, Nadeau JH. (2002) Genetic and 
molecular control of folate-homocysteine metabolism in mutant mice. Mamm Genome 
13 (5): 259-267 
Gridley G, Mclaughlin JK, Block G, Blot WJ, Gluch M, Frauumani JF Jr. (1992) Vitamin 
supplement use and reduced risk of oral and pharyngeal cancer. Am J Epidemiol 135 
(10): 1083-1092 
Istiadjid M, Santoso E, Rohman S. (2005) Decreased TGF-B1 and IGF-1 protein 
expression in rat embryo skull bone in folic acid-restricted diet. J Nutr Biochem17 (1): 
51-56  
  34 
 
Katula KS, Heinloth AN, Paules RS. (2007) Folate deficiency in normal human 
fibroblasts leads to altered expression of genes primarily linked to cell signaling, the 
cytoskeleton and extracellular matrix. J Nutr Biochem18: 541-552 
Kim Y. (2004) Folate and DNA methylation: A mechanistic link between folate 
deficiency and colorectal cancer. Cancer Epidem Biomar 13: 511-519 
Lee JE, Giovannucci E, Smith-Warner SA, Spiegelman D, Willett WC, Curhan GC. 
(2006) Intakes of Fruits, Vegetables, Vitamins A, C, and E, and Carotenoids and Risk of 
Renal Cell Cancer. Cancer Epidemiol Biomar Prev 2006 15: 2445-2452 
Liang H, Chen Q, Coles AH, Anderson SJ, Pihan G, Bradley A, Gerstein R, Jurecic R, 
Jones SN. (2003) Wnt5a inhibits B cell proliferation and functions as a tumor suppressor 
in hematopoietic tissue. Cancer Cell 4 (5): 349-360 
Lin Y, Kikuchi S, Tamakoshi A, Yagyu K, Obata Y, Inaba Y, Kurosawa M, Kawamura 
T, Motohashi Y, Ishibashi T. (2006) Dietary habits and pancreatic cancer risk in a cohort 
of middle-aged and elderly Japanese. Nutr Cancer 56 (1): 40-49 
Luebeck G, Moolgavkar S. (2002) Multistage carcinogenesis and the incidence of 
colorectal cancer. P Natl Acad Sci USA 99 (23): 15095-15100  
Lugli A, Zlobec I, Minoo P, Baker K, Tornillo L, Terracciano L, Jass J R. (2007) 
Prognostic significance of the wnt signalling pathway molecules APC, beta-catenin and 
E-cadherin in colorectal cancer - a tissue microarray-based analysis. Histopathology 50 
(4): 453-464 
Ma DW, Finnell RH, Davidson LA, Callaway ES, Spiegelstein O, Piedrahita JA, 
Salbaum JM, Kappen C, Weeks BR, James J, Bozinov D, Lupton JR, Chapkin RS. 
(2005) Folate transport gene inactivation in mice increases sensitivity to colon 
carcinogenesis. Cancer Res 65 (3): 887-897 
Mashiyama S, Hansen C, Roitman E, Sarmiento S, Leklem J, Shultz T, Ames B. (2008) 
An assay for uracil in human DNA at baseline: effect of marginal vitamin B6 deficiency. 
Anal Biochem 372 (1): 21-31  
Miller JR, Hocking AM, Brown JD, Moon RT. (1999) Mechanism and function of signal 
transduction by the Wnt/beta-catenin and Wnt/Ca2+ pathways. Oncogene 18 (55): 7860-
7872 
Moon R, Bowerman B, Boutros M, Perrimon N. (2002) The promise and perils of Wnt 
signaling through β-catenin. Science 296 (5573): 1644-1646 
Novakovic P, Stempak JM, Sohn KJ, Kim YI. (2006) Effects of folate deficiency on gene 
  35 
 
expression in the apoptosis and cancer pathways in colon cancer cells. Carcinogenesis 27 
(5): 916-924 
Nusse R. (2005) Wnt signaling in disease and in development. Cell Res 15 (1): 28-32 
Playford M, Bicknell D, Bodmer W, Macaulay V. (2000) Insulin-like growth factor 1 
regulates the location, stability, and transcriptional activity of beta-catenin. P Natl Acad 
Sci USA 9 (22): 12103-12108 
Polakis P. (2000) Wnt signaling and cancer. Genes Dev 14 (15): 1837-1851 
Shiratsuchi H, Nakashima T, Hirakawa N, Toh S, Nakagawa T, Saito T, Tsuneyoshi N, 
Komune S. (2007) β-catenin nuclear accumulation in head and neckmucoepidermoid 
carcinoma: its role in cyclin D1 overexpression and and tumor pregression. Head Neck J 
Sci Spec 29 (6): 577-584 
Sierra J, Yoshida T, Joazeiro C, Jones K. (2006) The APC tumor suppressor counteracts 
beta catenin activation and H3K4 methylation at Wnt target genes. Genes Dev 20: 586-
600 
Topol L, Jiang X, Choi H, Garrett-Beal L, Carolan PJ, Yang Y. (2003) Wnt-5a inhibits 
the canonical Wnt pathway by promoting GSK-3-independent beta-catenin degradation. J 
Cell Biol 162 (5): 899-908 
Ulrich C. (2005) Nutrigenetics in cancer research-Folate metabolism and colorectal 
cancer. J Nutr (135): 2698-2702 
Veeman MT, Axelrod JD, Moon RT. (2003) A second canon: Functions and mechanisms 
of beta-catenin-independent Wnt signaling. Dev Cell 5 (3): 367-377 
Wohrle S, Wallmen B, Hecht A. Differential control of Wnt target genes involves 
epigenetic mechanisms and selective promoter occupancy by TCF’s. Mol Cell Biol 27 
(23): 8164-8177  
Wilhelm P, Breuhahn K, Fischer F, Zilkens C, Pietsch T, Petmecky K, Eilers R, Dienes 
H, Schirmacher P. (2003) Beta-catenin accumulation in the progression of human 
hepatocarcinogenesis correlates with loss of E-cadherin and accumulation of p53, but not 
with expression of conventional Wnt-I target genes. J Pathol 201: 250-259 
Willett WC, Stampfer MJ, Colditz GA, Rosner BA, Speizer FE. (1990) Relation of meat 
fat and fiber intake to the risk of colon cancer in a prospective study among women. New 
Engl J Med 323 (24): 1664-1672 
Winter-Vann AM, Kamen BA, Bergo MO, Young SG, Melnyk S, James SJ. (2003) 
Targeting Ras signaling through inhibition of carboxyl methylation: an unexpected 
  36 
 
property of methotrexate. P Natl Acad Sci USA 100: 6529-6534 
Zhenhua L, Sang-Woon, Crott J, Keyes MK, Hyeran J, Smith D, Kim M, Laird P, 
Bronson R, Mason JB. (2007) Mild depletion of dietary folate combined with other B 
vitamins alters multiple components of the wnt pathway in mouse colon. J Nutr 137: 
2701-2708 
Zingg JM, Jones PA. (1997) Genetic and epigenetic aspects of DNA methylation on 
genome expression, evolution, mutation and carcinogenesis. Carcinogenesis 18 (5) : 869-
882
  37 
 
 
 
APPENDIX A. DMEM CUSTOM MEDIUM 
The following ingredients are combined in water to a volume of 4 liters. The pH of the 
medium is then adjusted to between 7.2 and 7.6 using 1N HCl. Medium is then filter 
sterilized using a .2 um filter.  
     
Inorganic Salts mg  Vitamins mg 
CaCl2 2H2O 1059.68  Choline Chloride 16 
Fe(No3)3 9H2O 0.4  Folic Acid 8 
KCl 1600  myo-Inositol 28.8 
MgSO4 7H20 (dried) 308.04  Nicotinamide 16 
NaCl 25,600  
Pantothenate 
Calcium  16 
NaH2PO4 H2O 500  Pyridoxal HCl 16 
     Riboflavin 1.6 
Amino Acids    Thiamine HCl 16 
L-Arginine HCL 336      
L-Cystine 192  Other components   
L-Glutamine 2336  D-Glucose 18000 
Glycine 120  Phenol Red 60 
L-Histidine HCl 
H2O 168  Sodium Pyruvate 440 
L-Isoleucine 420  Sodium Bicarbonate 14800 
L-Leucine 420  Hepes 14280 
L-Lysine HCl 584    
L-Methionine 120    
L-Phenylalanine  264    
L-Serine 168    
L-Threonine 380    
L-Tryptophan 64    
L-Tyrosine 288    
L-Valine 376    
http://www.atcc.org/common/documents/pdf/30-2002.pdf 
 
